Evidence map›Paper›PMID 36000731›Full record

ArticlemBio2022

Multiple Introductions of SARS-CoV-2 Alpha and Delta Variants into White-Tailed Deer in Pennsylvania.

Andrew D Marques, Scott Sherrill-Mix, John K Everett, Hriju Adhikari, Shantan Reddy, Julie C Ellis, Haley Zeliff, Sabrina S Greening, Carolyn C Cannuscio, Katherine M Strelau and 6 more

Open access · goldAbstract read
In one paragraph

Article in mBio, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 69 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. CROI 2024: Summary of Basic Science Research in HIV.Topics in antiviral medicine · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Andrew D MarquesDepartment of Microbiology, Perelman School of Medicine, University of Pennsylvaniagrid.25879.31, Philadelphia, Pennsylvania, USA.
Scott Sherrill-MixDepartment of Microbiology, Perelman School of Medicine, University of Pennsylvaniagrid.25879.31, Philadelphia, Pennsylvania, USA.
John K EverettDepartment of Microbiology, Perelman School of Medicine, University of Pennsylvaniagrid.25879.31, Philadelphia, Pennsylvania, USA.
Hriju AdhikariDepartment of Microbiology, Perelman School of Medicine, University of Pennsylvaniagrid.25879.31, Philadelphia, Pennsylvania, USA.
Shantan ReddyDepartment of Microbiology, Perelman School of Medicine, University of Pennsylvaniagrid.25879.31, Philadelphia, Pennsylvania, USA.
Julie C EllisDepartment of Pathobiology, Wildlife Futures Program, University of Pennsylvaniagrid.25879.31 School of Veterinary Medicine, New Bolton Center, Kennett Square, Pennsylvania, USA.
Haley ZeliffDepartment of Pathobiology, University of Pennsylvaniagrid.25879.31 School of Veterinary Medicine, New Bolton Center, Kennett Square, Pennsylvania, USA.
Sabrina S GreeningDepartment of Pathobiology, Wildlife Futures Program, University of Pennsylvaniagrid.25879.31 School of Veterinary Medicine, New Bolton Center, Kennett Square, Pennsylvania, USA.
Carolyn C CannuscioLeonard Davis Institute of Health Economics, University of Pennsylvaniagrid.25879.31, Philadelphia, Pennsylvania, USA.
Katherine M StrelauLeonard Davis Institute of Health Economics, University of Pennsylvaniagrid.25879.31, Philadelphia, Pennsylvania, USA.
Ronald G CollmanPulmonary, Allergy and Critical Care Division; Department of Medicine; University of Pennsylvaniagrid.25879.31 Perelman School of Medicine; Philadelphia, Pennsylvania, USA.ORCID 0000-0002-0508-3701
Brendan J KellyDivision of Infectious Diseases; Department of Medicine & Department of Biostatistics, Epidemiology, and Informatics; Perelman School of Medicine, University of Pennsylvaniagrid.25879.31, Philadelphia, Pennsylvania, USA.ORCID 0000-0003-2023-646X
Kyle G RodinoDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvaniagrid.25879.31, Philadelphia, Pennsylvania, USA.
Frederic D BushmanDepartment of Microbiology, Perelman School of Medicine, University of Pennsylvaniagrid.25879.31, Philadelphia, Pennsylvania, USA.ORCID 0000-0003-4740-4056
Roderick B GagneDepartment of Pathobiology, Wildlife Futures Program, University of Pennsylvaniagrid.25879.31 School of Veterinary Medicine, New Bolton Center, Kennett Square, Pennsylvania, USA.
Eman AnisDepartment of Pathobiology, University of Pennsylvaniagrid.25879.31 School of Veterinary Medicine, New Bolton Center, Kennett Square, Pennsylvania, USA.
University of Pennsylvania · USUniversity of Pennsylvania Health System · USOffice of Infectious Diseases · US

Funding

Virus & Reservoirs CoreP30AI045008 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI Ronald G Collman · 1999 to 2026
$78.6M
NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities75N93021C00015 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI HENSLEY, SCOTT · 2021 to 2025
$50.7M
MERS coronavirus: antagonism of double-stranded RNA induced host response by accessory proteinsR01AI140442 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI Susan R Weiss · 2018 to 2026
$5.1M
The Lung DNA Virome in Health and DiseaseR33HL137063 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI BUSHMAN, FREDERIC D, COLLMAN, RONALD G · 2019 to 2021
$2.3M
Longitudinal analysis of respiratory tract microbiome change and sequence-based infection diagnosis during mechanical ventilationK23AI121485 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI KELLY, BRENDAN JOSEPH · 2016 to 2020
$965k
The Lung DNA Virome in Health and DiseaseR61HL137063 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI BUSHMAN, FREDERIC D, COLLMAN, RONALD G · 2017 to 2018
$605k
CDC HHSNHLBI NIH HHS R33 HL137063NHLBI NIH HHS R61 HL137063NIAID NIH HHS 75N93021C00015NIAID NIH HHS K23 AI121485NIAID NIH HHS P30 AI045008NIAID NIH HHS R01 AI140442
6 · The paper itself

Abstract

The SARS-CoV-2 pandemic began by viral spillover from animals to humans; today multiple animal species are known to be susceptible to infection. White-tailed deer, Odocoileus virginianus, are infected in North America at substantial levels, and genomic data suggests that a variant in deer may have spilled back to humans. Here, we characterize SARS-CoV-2 in deer from Pennsylvania (PA) sampled during fall and winter 2021. Of 123 nasal swab samples analyzed by RT-qPCR, 20 (16.3%) were positive for SARS-CoV-2. Seven whole genome sequences were obtained, together with six more partial spike gene sequences. These annotated as alpha and delta variants, the first reported observations of these lineages in deer, documenting multiple new jumps from humans to deer. The alpha lineage persisted in deer after its displacement by delta in humans, and deer-derived alpha variants diverged significantly from those in humans, consistent with a distinctive evolutionary trajectory in deer.

Indexed as

COVID-19DeerAnimalsHumansPennsylvaniaSARS-CoV-2animal reservoircoronavirusOdocoileus virginianusSARS-CoV-2white-tail deerzoonosis

Identifiers

PMID36000731
PMCPMC9600874
OpenAlexW4293177080

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.